Acute effects of beclomethasone on hyperpnea-induced bronchoconstriction

Medicine and Science in Sports and Exercise

Volumn 42, Issue 2, 2010, Pages 273-280

  Kippelen, Pascale ^a,b   Larsson, Johan ^c   Anderson, Sandra D ^a   Brannan, John D ^a   Delin, Ingrid ^c   Dahlen, Barbro ^c,d   Dahlen, Sven Erik ^c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

11 ; 9 ; Asthma; Exercise; Inhaled corticosteroids; Leukotriene e4; Mast cell activation; Prostaglandin F2

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; EXERCISE INDUCED ASTHMA; FEMALE; HUMAN; HYPERVENTILATION; INHALATIONAL DRUG ADMINISTRATION; MALE; MAST CELL; METABOLISM;

ADMINISTRATION, INHALATION; ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA, EXERCISE-INDUCED; BECLOMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERVENTILATION; MALE; MAST CELLS; YOUNG ADULT;

EID: 75149135700     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e3181b541b1     Document Type: Article

References (39)

1. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med. 1995;152:1107-1136
2. Anderson SD, Holzer K. Exercise-induced asthma: is it the right diagnosis in elite athletes? J Allergy Clin Immunol. 2000;106: 419-428
3. Argyros GJ, Roach JM, Hurwitz KM, Eliasson AH, Phillips YY. Eucapnic voluntary hyperventilation as a bronchoprovocation technique. Development of a standardized dosing schedule in asthmatics. Chest. 1996;109:1520-1524
4. 2 is a potent contractile agonist of human and guinea pig airways. J Clin Invest. 1987;79:978-983
5. 2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax. 2004;59:459-464
6. Bonsignore MR, Morici G, Riccobono L, et al. Airway inflam-mation in nonasthmatic amateur runners. Am J Physiol Lung Cell Mol Physiol. 2001;281:L668-76.
7. Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J. 2003;22:491-496
8. 2 release protects against mannitol-induced airway narrowing. Eur Respir J. 2006;27: 944-950
9. Cabral ALB, Conceição GM, Fonseca-Guedes CHF, Martins MA. Exercise-induced bronchospasm in children. Am J Respir Crit Care Med. 1999;159:1819-1823
10. Carroll NG, Mutavdzic S, James AL. Distribution and degranu-lation of airway mast cells in normal and asthmatic subjects. Eur Respir J. 2002;19:879-885
11. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for metha-choline and exercise challenge testing-1999. Am J Respir Crit Care Med. 2000;161:309-329
12. 2 in vivo. Thorax. 2004;59:453-455
13. Edmunds A, Tooley M, Godfrey S. The refractory period after exercise-induced asthma: its duration and relation to the severity of exercise. Am Rev Respir Dis. 1978;117:247-254
14. Erin EM, Zacharasiewicz AS, Nicholson GC, et al. Rapid anti-inflammatory effect of inhaled ciclesonide in asthma: a randomised, placebo-controlled study. Chest. 2008;134:740-745
15. Gibson PG, Saltos N, Fakes K. Acute anti-inflammatory effects of inhaled budesonide in asthma. A randomized controlled trial. Am J Respir Crit Care Med. 2001;163:32-36
16. 2 and leukotriene C in response to hyperosmolar stimulation of mast cells. Allergy. 2006;61:1473-1479
17. 4 is resistant to inhaled fluticasone propionate. J Allergy Clin Immunol. 2006;118:78-83.
18. Hurwitz KM, Argyros GJ, Roach JM, Eliasson AH, Phillips YY. Interpretation of eucapnic voluntary hyperventilation in the diagnosis of asthma. Chest. 1995;108:1240-1245
19. Jaffe. Creatinine-Jaffe's method. Blood Safety and Clinical Technology. Guidelines on Standard Operating Procedures in Clinical Chemistry. [cited 2009 June 18]. Available from: http://www.searo. who.int/en/section10/section17/ section53/section481-1755.htm.
20. Ketchell RI, Jensen MW, Lumley P, Wright AM, Allenby MI, O'Conner BJ. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma. J Allergy Clin Immunol. 2002;110:603-606
21. 4. Clin Exp Allergy. 2000;30:585-589
22. 4 in humans. Clin Exp Allergy. 1995;25:467-479
23. Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocar-bon beclomethasone: a cross-over study in healthy volunteers. Chest. 2002;122:510-516
24. McFadden ER, Lenner KA, Strohl KP. Postexertional airway rewarming and thermally induced asthma. J Clin Invest. 1986; 78:18-25.
25. Mendes ES, Pereira A, Danta I, Duncan RC, Wanner A. Comparative bronchial vasoconstrictive efficacy of inhaled glu-cocorticosteroids. Eur Respir J. 2003;21:989-993
26. Mickleborough TD, Murray RL, Ionescu AA, Lindley MR. Fish oil supplementation reduces severity of exercise-induced bron-choconstriction in elite athletes. Am J Respir Crit Care Med. 2003;168:1181-1189
27. 2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol. 1996;98:421-432
28. O'Sullivan S, Roquet A, Dahlén B, Dahlén S-E, Kumlin M. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy. 1998;228:1332-1339
29. O'Sullivan S, Roquet A, Dahlén B, et al. Evidence for mast cell activation during exercise-induced bronchoconstriction. Eur Respir J. 1998;12:345-350
30. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6:5-40.
31. 4 after exercise and attenuation of exercise-induced broncho-spasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax. 1997;52:1030-1035
32. Reiss TF, Sorkness CA, Stricker W, et al Effects of montelukast (MK-0476), a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. Thorax. 1997;52:45-48
33. Rundell KW, Jenkinson DM. Exercise-induced bronchospasm in the elite athlete. Sports Med. 2002;32:583-600.
34. Sly PD, Landau LI. Diurnal variation in bronchial responsiveness in asthmatic children. Pediatr Pulmonol. 1986;2:344-352
35. Smith CM, Anderson SD, Seale JP. The duration of action of the combination of fenoterol hydrobromide and ipratropium bromide in protecting against asthma provoked by hyperpnea. Chest. 1988; 94:709-717
36. Subbarao P, Duong M, Adelroth E, et al. Effect of ciclesonide dose and duration of therapy on exercise-induced bronchocon-striction in patients with asthma. J Allergy Clin Immunol. 2006; 117:1008-1013
37. Thio BJ, Slingerland GLM, Nagelkerke AF, Roord JJ, Mulder PGH, Dankert-Roelse JE. Effects of single-dose fluticasone on exercise-induced asthma in asthmatic children: a pilot study. Pediatr Pulmonol. 2001;32:115-121
38. + exchanger activity in human bronchial epithelial cells. J Biol Chem. 2005;280: 35807-35814
39. Zhou J, Lui DF, Liu C, et al. Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism. Allergy. 2008;63:1177-1185